| Vol. 10.18 – 13 May, 2021 |
| |
|
|
| Researchers showed that MEK inhibition enhanced PD-L1 expression while PD-L1 blockade upregulated MAPK signaling in mutant KRAS lung tumors. [Nature Communications] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists investigated the role of long non-coding RNAs (lncRNAs) in lung fibrosis. Scientists used a qRT-PCR assay to identify dysregulated lncRNAs in the lungs of mice with experimental, bleomycin-induced pulmonary fibrosis, and a series of molecular assays to assess the role of the novel lncRNA NONMMUT060091, designated as pulmonary fibrosis inhibitor, which was significantly downregulated in lung fibrosis. [Cell Death & Differentiation] |
|
|
|
| Investigators showed that administration of ISRIB, a small molecule that restores protein translation by EIF2B during activation of the integrated stress response, accelerated the differentiation of alveolar type 2 into alveolar type 1 cells. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Researchers investigated the role of Fgfr2 signaling in alveolar epithelial type 2 cells across the lifespan and during adult regeneration after influenza infection. [Cell Reports] |
|
|
|
|
| Scientists advanced the model system and identified a non-genetic mechanism of resistance that drive recovery and regrowth in a subset of cells. [eLife] |
|
|
|
| Researchers showed that vimentin phosphorylated by PLK1, triggered TGF-β-signaling, which consequently led to metastasis and PD-L1 expression for immune suppression in lung adenocarcinoma. [Cell Death & Differentiation] |
|
|
|
| Investigators found that YTHDF2 was significantly upregulated in lung adenocarcinoma (LUAD) compared with paracancerous normal tissues, and YTHDF2 knockdown drastically inhibited, while its overexpression promoted, cell growth, colony formation and migration of LUAD cells in vitro. [Cell Death & Disease] |
|
|
|
| By performing whole-exome sequencing of 48 small-cell carcinoma of the esophagus (SCCE) and 64 small-cell lung cancer (SCLC) tumor samples, respectively researchers have shown that the number of driver mutations in SCCE was significantly lower than in SCLC [Cell Death & Disease] |
|
|
|
| Investigators elucidated the expression and role of long non-coding RNA – PCAT – 1, a potential biomarker for drug resistance and a therapeutic target for NSCLC, in gefitinib resistance in NSCLC cells. [Respiratory Research] |
| |
|
|
|
| Cross-cutting themes and challenges were identified using qualitative methods for patients, healthcare professionals and service delivery, with a clear need for continued studies to guide evidence-based decision-making. [British Journal of Cancer] |
|
|
|
| Environmental pollutants, such as particulate matter, ozone, and other products of combustion, both stimulate and disrupt the function of the innate immune system of the lung, leading to the potential for pathologic consequences. [Current Allergy and Asthma Reports] |
|
|
|
|
| Merus, Inc. announced new collaborations in Israel, Italy and Spain to expand molecular screening opportunities for patients with cancers that may have neuregulin 1 fusions and to raise awareness of the Merus eNRGy clinical trial of its bispecific antibody zenocutuzumab. [Merus, Inc. (Business Wire, Inc.)] |
|
|
|
|
| October 27 – 29, 2021 Tokyo, Japan |
|
|
|
|
|
| University of Illinois at Chicago – Chicago, Illinois, United States |
|
|
|
| Brigham and Women’s Hospital – Boston, US Minor Outlying Islands |
|
|
|
| University of Exeter – Exeter, United Kingdom |
|
|
|
| University of Texas MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| Helmholtz Zentrum München – Neuherberg (bei München), Germany |
|
|
|
|